Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yiruide is a Chinese medical device and neurotechnology company focused on brain science, neuromodulation, and mental health care rather than drug development. The company originated as Wuhan Yiruide Medical Treatment Equipment New Technology in 2007 and has expanded into Yiruide Group, offering transcranial magnetic stimulation, magnetic field stimulation, transcranial electrical stimulation, sleep-related devices, functional near-infrared brain imaging, and associated software systems. Its products are used broadly across hospitals and rehabilitation settings in China, with the company describing itself as a leading domestic supplier in transcranial magnetic stimulation and related neuroregulation equipment. Yiruide appears to be a revenue-generating commercial-stage healthcare company with strong activity in clinical deployment, academic engagement, and intellectual property around non-invasive brain stimulation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yiruide.